Argent Trust Company’s Novartis NVS Stock Holding History

Argent Trust Company’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.12M	Sell	13,645 -22	-0.2%	-$1.96K	0.5%	61
2015 Q2	$1.2M	Buy	+13,667	New	+$1.25M	0.48%	64
2014 Q2	–	Sell	-14,476	Closed	-$1.1M	–	176
2014 Q1	$1.1M	Sell	14,476 -279	-2%	-$20.3K	0.42%	69
2013 Q4	$1.06M	Sell	14,755 -122	-0.8%	-$8.48K	0.4%	73
2013 Q3	$1.02M	Sell	14,877 -112	-0.7%	-$7.41K	0.43%	69
2013 Q2	$950K	Buy	+14,989	New	+$975K	0.42%	68

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Institutional Capital Chicago, Illinois $6.75B AUM 3.44% 1-Year Est. Return

Argent Trust Company's NVS Position: Q3 2015 in Review

Argent Trust Company reduced its Novartis (NVS) stake by 0.16% in Q3 2015, selling an estimated $1.96K and leaving 13,645 shares worth $1.12M. The position accounts for 0.5% of the portfolio, ranked #61.

Argent Trust Company first reported a position in NVS in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.2M in Q2 2015. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

Argent Trust Company held 13,645 shares of Novartis worth $1.12M as of Q3 2015.
Argent Trust Company sold 22 Novartis shares in Q3 2015, an estimated $1.96K.
Novartis made up 0.5% of Argent Trust Company's portfolio in Q3 2015, its #61 holding.
Argent Trust Company first reported a position in Novartis in Q2 2013 and has held it in 6 quarters since.
Argent Trust Company's Novartis position peaked at $1.2M in Q2 2015.
926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Argent Trust Company's 13F filing for Q3 2015, filed 13 Nov 2015.